ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Algal oil start-up Solazyme has filed for a $100 million initial public offering of stock. The move comes after two other renewable materials firms, Amyris and Gevo, also went public in recent months. The offering will be a test of the market’s interest in algae firms, of which Solazyme is one of many. Rather than rely on photosynthesis to grow algae, the company uses a genetically modified strain that feeds on sugar in fermentation tanks. Target markets for the oil are fuels, chemicals, nutrition, and personal care, the filing says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter